Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Bank Stocks Alert: Why Michael Burry Says There’s No Need to Worry About SVB’s Collapse

By Josh Enomoto, InvestorPlace Contributor

Although Michael Burry sounded off with an optimistic view about bank stocks, investors should tread waters carefully.

Solar Stocks Alert: Why Wells Fargo Sees RUN, NOVA Stocks Soaring

By Josh Enomoto, InvestorPlace Contributor

Although Wells Fargo posted an optimistic tone about solar stocks, this energy sector faces significant economic hurdles ahead.

7 Long-Term Stocks That Will Reward Patient Investors

By Josh Enomoto, InvestorPlace Contributor

While circumstances in the market may be shaky due to stability concerns, these long-term stocks to buy offer much-needed confidence.

7 Biotech Stocks That Could Be the Next Big Thing

By Josh Enomoto, InvestorPlace Contributor

Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

By Josh Enomoto, InvestorPlace Contributor

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Load More